Eximis is focused on delivering contained specimen removal solutions that provide a safe and efficient solution for patients andpractitioners. Meet the experienced leadership team that is committed to bringing this innovative platform to market.

Donna Ford-Serbu
Donna Ford-Serbu, CEO

22 years in the medical device industry (Covidien, Spectranetics); General Manager, Sales & Marketing, Business Development, Strategy.

Bob Luzzi
Bob Luzzi, Vice President of R&D

Bob has over 29 years in the medical device industry; Bob is an inventor on 50 pending patents and is a Certified Patent Agent.

William Gregg
William Gregg, Director of R&D

25 years in the medical device industry (Fisher Imaging, Covidien); Led Covidien generator R&D group (>$610M annual revenue)

Chris Underwood
Chris Underwood, Director of Operations

16 years of medical device (Cardinal Health, Medtronic, Covidien, and Mountainside Medical); Director of Engineering, Mechanical engineering Manager (R&D)


Eximis Board of Directors

Ryan Drant
Ryan Drant

  • Founder and Managing Director at Questa Capital
  • Healthcare investment specialist
  • Served on 35 board of directors

Scott Button
Scott Button

  • Managing Director of Venture Investors
  • Over 15 years of portfolio company board experience

Scott Hutton
Scott Hutton

  • Currently CEO, BIODESIX, INC
  • 16 YRS Medical Device Experience
  • VP AND GM MEDTRONIC NEUROSURGERY 2012-2017

Ted Lamson
Ted Lamson

  • Co-Founder, CEO, CTO of NeoTract (acquired by Teleflex)
  • Over 25 yrs in medical devices
  • Deep start-up experience

Donna Ford-Serbu
Donna Ford-Serbu, CEO

  • 21 years in the medical device industry (Covidien, Spectranetics)
  • General Manager, Sales & Marketing, Business Development, Strategy

Brian Butler
Brian Butler

  • Partner, Questa Capital
  • Medical device, life sciences investment specialist